Peter Zwanzger
Department of Psychiatry
Ludwig Maximilian University
Nussbaumstrasse 7
80336 Munich
Germany
[email]@psy.med.uni-muenchen.de
Name/email consistency: high
- Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety. Zwanzger, P., Jarry, H., Eser, D., Padberg, F., Baghai, T., Schule, C., Ella, R., Möller, H.J., Rupprecht, R. J. Neural. Transm (2003)
- Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Zwanzger, P., Eser, D., Aicher, S., Schüle, C., Baghai, T.C., Padberg, F., Ella, R., Möller, H.J., Rupprecht, R. Neuropsychopharmacology (2003)
- Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers. Zwanzger, P., Eser, D., Padberg, F., Baghai, T.C., Schule, C., Rötzer, F., Ella, R., Möller, H.J., Rupprecht, R. Depress. Anxiety (2003)
- Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Zwanzger, P., Baghai, T.C., Schuele, C., Ströhle, A., Padberg, F., Kathmann, N., Schwarz, M., Möller, H.J., Rupprecht, R. Neuropsychopharmacology (2001)
- Treatment of mitral valve prolapse and panic disorder with metoprolol. Zwanzger, P., Baghai, T., Schule, C., Rupprecht, R. World J. Biol. Psychiatry (2000)